Sphingomyelin and progression of renal and coronary heart disease in individuals with type 1 diabetes
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sphingomyelin and progression of renal and coronary heart disease in individuals with type 1 diabetes
Authors
Keywords
-
Journal
DIABETOLOGIA
Volume 63, Issue 9, Pages 1847-1856
Publisher
Springer Science and Business Media LLC
Online
2020-06-20
DOI
10.1007/s00125-020-05201-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study
- (2019) Megumi Oshima et al. DIABETOLOGIA
- SMPDL3b modulates insulin receptor signaling in diabetic kidney disease
- (2019) A. Mitrofanova et al. Nature Communications
- Crosstalk Between Lipids and Mitochondria in Diabetic Kidney Disease
- (2019) G. Michelle Ducasa et al. Current Diabetes Reports
- Dyslipidaemia in nephrotic syndrome: mechanisms and treatment
- (2017) Shipra Agrawal et al. Nature Reviews Nephrology
- Sphingolipids Contribute to Human Atherosclerotic Plaque InflammationHighlights
- (2016) Andreas Edsfeldt et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Muscle sphingolipids during rest and exercise: a C18:0 signature for insulin resistance in humans
- (2016) Bryan C. Bergman et al. DIABETOLOGIA
- Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol
- (2016) Reijo Laaksonen et al. EUROPEAN HEART JOURNAL
- Sphingolipids and phospholipids in insulin resistance and related metabolic disorders
- (2016) Peter J. Meikle et al. Nature Reviews Endocrinology
- Serum sphingolipids: relationships to insulin sensitivity and changes with exercise in humans
- (2015) Bryan C. Bergman et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Fenofibrate lowers atypical sphingolipids in plasma of dyslipidemic patients: A novel approach for treating diabetic neuropathy?
- (2015) Alaa Othman et al. Journal of Clinical Lipidology
- Different Lipid Variables Predict Incident Coronary Artery Disease in Patients With Type 1 Diabetes With or Without Diabetic Nephropathy: The FinnDiane Study
- (2014) Nina Tolonen et al. DIABETES CARE
- Dose-Dependent Effects of Rosuvastatin on the Plasma Sphingolipidome and Phospholipidome in the Metabolic Syndrome
- (2014) Theodore W. K. Ng et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Sphingomyelinase-Like Phosphodiesterase 3b Expression Levels Determine Podocyte Injury Phenotypes in Glomerular Disease
- (2014) T.-H. Yoo et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Decreased plasma levels of select very long chain ceramide species Are associated with the development of nephropathy in type 1 diabetes
- (2014) Richard L. Klein et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Association of Kidney Disease Outcomes With Risk Factors for CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study
- (2013) Wei Yang et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- A New Equation to Estimate Glomerular Filtration Rate
- (2013) Andrew S. Levey et al. ANNALS OF INTERNAL MEDICINE
- Beyond LDL-C lowering: Distinct molecular sphingolipids are good indicators of proprotein convertase subtilisin/kexin type 9 (PCSK9) deficiency
- (2013) Minna T. Jänis et al. ATHEROSCLEROSIS
- Triglyceride-cholesterol imbalance across lipoprotein subclasses predicts diabetic kidney disease and mortality in type 1 diabetes: the FinnDiane Study
- (2013) V.-P. Mäkinen et al. JOURNAL OF INTERNAL MEDICINE
- Biological functions of sphingomyelins
- (2013) J. Peter Slotte PROGRESS IN LIPID RESEARCH
- Genome-Wide Association Study Identifies Novel Loci Associated with Circulating Phospho- and Sphingolipid Concentrations
- (2012) Ayşe Demirkan et al. PLoS Genetics
- Insulin Resistance, Hyperglycemia, and Atherosclerosis
- (2011) Karin E. Bornfeldt et al. Cell Metabolism
- Inhibition of ceramide synthesis reverses endothelial dysfunction and atherosclerosis in streptozotocin-induced diabetic rats
- (2011) Li Chun et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Metabolic Diversity of Progressive Kidney Disease in 325 Patients with Type 1 Diabetes (the FinnDiane Study)
- (2011) Ville-Petteri Mäkinen et al. JOURNAL OF PROTEOME RESEARCH
- Sphingomyelin is associated with kidney disease in type 1 diabetes (The FinnDiane Study)
- (2011) Ville-Petteri Mäkinen et al. Metabolomics
- Association of Plasma Sphingomyelin Levels and Incident Coronary Heart Disease Events in an Adult Population
- (2009) Joseph Yeboah et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes
- (2009) P.-H. Groop et al. DIABETES
- Metabolic Phenotypes, Vascular Complications, and Premature Deaths in a Population of 4,197 Patients With Type 1 Diabetes
- (2008) V.-P. Makinen et al. DIABETES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started